Urinary Bladder Neoplasms: all 1,649 studies
Page 14 of 17. Open to participants first (427), then studies with results posted, then the rest; newest registration first within each.
- Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical CystectomyCompletedNCT02345473
- Celecoxib for the Treatment of Non-muscle Invasive Bladder CancerCompletedNCT02343614Phase 2
- High Resolution Imaging for Early and Better Detection of Bladder CancerCompletedNCT02340650
- Enhanced Recovery After Radical Cystectomy StudyCompletedNCT02328417
- PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder CancerCompletedNCT02326168Early Phase 1
- Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder CancerCompletedNCT02311101Phase 1
- Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC PatientsCompletedNCT02307487Phase 2
- Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot StudyCompletedNCT02298998
- Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer CharacterizationCompletedNCT02287701Not applicable
- SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study IWithdrawnNCT02254915Phase 3
- An International Randomized Study to Compare SPIES Versus WLICompletedNCT02252549Not applicable
- Urinary Diversion During Robotic Assisted Radical Cystectomy in Patients With Bladder CancerWithdrawnNCT02252393Not applicable
- Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer CohortsCompletedNCT02246738
- Radical Cystectomy, Nutrition and ConvalescenceCompletedNCT02238886Not applicable
- Effect of Glycopyrrolate and Atropine on Catheter-Related Bladder DiscomfortStatus unknownNCT02228473Not applicable
- Prospective Clinical Trial - Obturator Reflex Predictors and BlockageStatus unknownNCT02228330Not applicable
- IFACT: Incidental Findings in Advanced Cancer TherapyCompletedNCT02217891
- Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder CancerCompletedNCT02214602Phase 4
- Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved ImagingCompletedNCT02203136
- Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the BladderActive, not recruitingNCT02202772Phase 1/2
- Intensive Smoking and Alcohol Cessation Intervention in Bladder Cancer Surgery PatientsCompletedNCT02188446Not applicable
- Compare the Quality of Life Between Patients With Conduit Diversions or Orthotopic NeobladdersStatus unknownNCT02174185
- Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-IrradiationCompletedNCT02170181
- Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract CancerActive, not recruitingNCT02170090Phase 3
- LCI-GU-BLA-SPEC-001: Aurora Kinase Expression in Muscle-Invasive Bladder CancerTerminatedNCT02164942
- FIRBladd - Use of Infrared Spectroscopy in the Diagnosis of Bladder TumorsCompletedNCT02149862Not applicable
- A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical CystectomyCompletedNCT02145871Phase 3
- Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder CancerWithdrawnNCT02143804Phase 2
- Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission TomographyCompletedNCT02139371Early Phase 1
- A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder CancerActive, not recruitingNCT02138734Phase 1/2
- Optimized Treatment Strategy for HighGrade1 (HGT1) Bladder Cancer Based on Substaging: a Prospective Observational Cohort StudyCompletedNCT02113501
- Alisertib in Chemotherapy-pretreated Urothelial CancerCompletedNCT02109328Phase 2
- Use of PET/MRI Tracer to Further Understanding of Prostate Cancer DevelopmentCompletedNCT02106416Not applicable
- A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of UrineCompletedNCT02101931Phase 3
- Sevoflurane Versus Desflurane for Catheter-related Bladder DiscomfortCompletedNCT02096224Not applicable
- Molecular Markers of Chemosensitivity for Bladder CancerStatus unknownNCT02074241
- Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder CancerStatus unknownNCT02074189Phase 3
- Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder CancerStatus unknownNCT02070120Phase 2
- Biomarker Identification for Bladder Cancer PatientsTerminatedNCT02053662
- Perioperative Oral Nutrition Intervention for Patients Undergoing Radical CystectomyCompletedNCT02050451Not applicable
- CVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200)CompletedNCT02043665Phase 1
- Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical CystectomyCompletedNCT02039310
- Detection of K14 in Bladder Cancer With a Non Invasive TechniqueTerminatedNCT02027649
- Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder CancerCompletedNCT02007005Phase 1/2
- Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer.CompletedNCT02001857Phase 4
- Single Subject Neratinib in Bladder Cancer (NRR)No longer availableNCT01956253
- Severity of Overactive Bladder Symptoms in Patients After Synergo TreatmentCompletedNCT01955408
- Adjuvant Radiation for High Risk Bladder CancerTerminatedNCT01954173Not applicable
- Intravesical Natural Baobab Oil in the Management of BCG-induced Lower Urinary Tract SymptomsCompletedNCT01939756Phase 1/2
- Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy "PROBE"CompletedNCT01935466
- MRI and Bladder Cancer ChemotherapyWithdrawnNCT01922232
- Intravesical Adjuvant Electromotive Mitomycin-CCompletedNCT01920269Phase 2/3
- PET/MRI and Biomarkers in Bladder CancerCompletedNCT01918592Not applicable
- An Educational Intervention for Patients With Bladder CancerCompletedNCT01915121Not applicable
- Pilot Study of BC-819/PEI and BCG in Patients With Superficial Transitional Cell Bladder CarcinomaCompletedNCT01878188Phase 1
- Clasic Laryngeal Mask Airway(C-LMA) and I-gel Releated Regurgitation and ComplicationsStatus unknownNCT01876836Phase 4
- Tranexamic Acid During Cystectomy Trial (TACT)CompletedNCT01869413Phase 2/3
- Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot StudyCompletedNCT01868087Early Phase 1
- Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersCompletedNCT01846520Not applicable
- Trial of Prehabilitation in Vulnerable Patients Undergoing Cystectomy for Bladder CancerCompletedNCT01840137Not applicable
- Prehabilitation to Enhance Postoperative Functional Capacity Following Radical CystectomyCompletedNCT01836978Not applicable
- Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial CarcinomaCompletedNCT01828736Phase 2
- Neoadjuvant Rapamycin in Patients Undergoing Radical CystectomyCompletedNCT01827618Early Phase 1
- Comparison of Two Insertion Technique of I-gelStatus unknownNCT01826565Not applicable
- Improving Sensitivity of Urine Cytology for Bladder CancerWithdrawnNCT01826097Not applicable
- Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder CancerCompletedNCT01824329Phase 2
- Perioperative Chemotherapy for Patients With Locally Advanced Bladder CancerCompletedNCT01812369Phase 3
- Endoscopic Subsurface Optical Imaging for Cancer DetectionCompletedNCT01810445
- Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBCCompletedNCT01803295Not applicable
- Neoadjuvant Chemotherapy in Locally Advanced Bladder CancerCompletedNCT01801644Not applicable
- A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC)WithdrawnNCT01799499Not applicable
- The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up StudyStatus unknownNCT01785537
- Study of Outcomes After Surgery/Treatment to Treat Bladder CancerCompletedNCT01776138
- Adaptive Radiotherapy Using Plan Selection for Bladder CancerCompletedNCT01762527Not applicable
- Endoscopic Resection of Bladder TumorsCompletedNCT01750970Not applicable
- Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder CancerCompletedNCT01738815Early Phase 1
- Adjuvant Post-radical Cystectomy Treatment for Bladder CancerCompletedNCT01734798Phase 3
- Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder CancerCompletedNCT01731652Phase 2
- Salvage Docetaxel for Pretreated Urothelial CancerCompletedNCT01711112Phase 2
- Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder CancerCompletedNCT01706185
- Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial CancerWithdrawnNCT01700010Phase 2
- Evaluation of Ultrasound Probe for Use in Bladder RadiotherapyStatus unknownNCT01698359
- The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder CancerCompletedNCT01697306Phase 2
- Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid TumorCompletedNCT01684098Phase 2
- Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9)Status unknownNCT01675219Phase 3
- Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative StudyCompletedNCT01665586Not applicable
- Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder CancerCompletedNCT01655745Not applicable
- Safety and Tolerability Study Which Evaluate Intravesical Instillation With Mitomycin C Mixed With TC-3 Drug Retaining Hydrogel Device In Patients With Muscle Invasive Bladder CancerCompletedNCT01648010Not applicable
- Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial CancerWithdrawnNCT01639521Phase 2
- Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionCompletedNCT01638533Phase 1
- Adjuvant Intraarterial Chemotherapy Following Surgery to Treat Locally Advanced Bladder CancerCompletedNCT01627197Phase 3
- PF-03446962 in Relapsed or Refractory Urothelial CancerCompletedNCT01620970Phase 2
- Clinical Trial Using Bipolar Technology for Transurethral Resection of Bladder TumorStatus unknownNCT01581723Phase 3
- Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder CancerTerminatedNCT01563796
- Detection of Bladder Tumors After 30 Min Instillation of HexvixTerminatedNCT01551407Phase 2
- Evaluation Of Zetiq's Novel Cell Detect Technology For Detection Of Bladder Cancer In Urine CytologyStatus unknownNCT01551342
- Efficacy of Diclofenac BCG IrrigationsStatus unknownNCT01542567Phase 3
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsCompletedNCT01522820Phase 1
- BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) PatientsCompletedNCT01498172Phase 1
- Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid TumorsTerminatedNCT01496534Phase 1